PGY2 Oncology Pharmacy Residency

banner

The PGY2 Oncology Pharmacy Residency conducted by TTUHSC Jerry H. Hodge School of Pharmacy, Dallas, Texas is accredited by ASHP.

Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Description

The PGY2 specialty residency in Oncology Pharmacy Practice at Texas Tech University Health Sciences Center School of Pharmacy Dallas/Ft. Worth Regional Campus, in conjunction with UT Southwestern Medical Center, is designed to produce practitioners who exhibit excellence in the pharmaceutical care of hematology/oncology patients. An oncology clinical specialist should possess a mastery of clinical skills needed to practice in a wide range of patient care settings and a solid knowledge base in oncology pharmacotherapy.

The residency provides the environment necessary to obtain the knowledge and skills needed to care for patients with a wide range of disease states. Core disease state experiences within this residency include lung, breast, prostate, colorectal cancer, leukemia, lymphoma, and bone marrow transplant among other malignancies. The resident may choose electives based on their career goals. In addition to patient care responsibilities, the resident will be involved in teaching activities, including didactic teaching, problem-based learning facilitation and precepting experiential clerkship students, as well as a residency research project. The program will foster the development of an independent and versatile practitioner and is designed to produce well rounded, independent professionals through interrelated experiences in teaching, research, and professional activities.

Practice Excellence

Develop an expert level knowledge base in oncology pharmacotherapy
Develop solid patient care skills in the inpatient and outpatient settings
Should achieve excellence in core oncology disease states
Develop a sound understanding of pharmacy practice management
Establish one’s self as an integral member of a health care team

Scholastic Excellence

Demonstrate proficiency in teaching in both didactic and small group learning environments
Develop effective precepting skills
Generate new knowledge in oncology pharmacotherapy
Interpret and disseminate knowledge in oncology pharmacotherapy

Individual Excellence

Develop and improve upon a system of self-assessment skills
Demonstrate exemplary verbal and written communication skills
Utilize a system for balancing multiple work-related and personal responsibilities
Understand the importance of professionalism through participation in pharmacy

For additional information, please refer to the ASHP PGY2 Oncology Pharmacy Residency Education Goals and Objectives.

The residency experiences are divided into month long blocks. The resident is required to take all of the required rotations throughout the year with the option to integrate the elective rotations throughout the residency based on the resident’s interest. All required rotations are within UT Southwestern Medical Group at either Clements University Hospital or the Simmons Comprehensive Cancer Center. Addition elective rotations may be offered at Children’s Medical center and the North Texas VA Health Care System.

Required Rotations (All 4 weeks unless otherwise specified)

Inpatient Medical Oncology (6 Weeks)
Inpatient Heme Malignancies I
Inpatient Heme Malignancies II
Outpatient BMT I
Outpatient BMT II
Outpatient Breast Cancer (3 weeks)
Outpatient Solid Oncology I
Outpatient Solid Oncology II
Outpatient Investigational Drug Service

Elective Rotations

Infectious Disease (pharmacist/physician precepted)
Others by request – as able to provide

Longitudinal Rotations

Resident Research Project
Oncology Pharmacy Administration
Academia
Cancer Center Staffing

Residents are appointed as Assistant Instructors with Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy (SOP). Teaching activities for residents are designed to complement practice activities while allowing the resident to experience a variety of teaching methods. Residents will be required to demonstrate skills necessary to function in an academic setting by completing the following activities:

Didactic Teaching
Two hours of formal didactic lectures within the school of pharmacy programs will be required. The courses that are to be taught will be based on availability and resident interest.

Problem-Based Learning
Involvement as a group facilitator in the small group, problem-based learning, courses is required for residents. The purpose of this course series is to provide specific opportunities for students to apply knowledge from the classroom setting in a hands-on environment. The Clinical Correlations courses allow for reinforcement of foundational concepts, integration of knowledge and skills from multiple courses in relation to the practice of pharmacy, and demonstration of individual student mastery of core objectives. The course focuses on practical application of concepts in science and the practice of pharmacy within an integrated, applied, small-group learning environment. It also emphasizes the relationships between therapeutics, medication safety, pharmacy operations. Key foundational concepts in science and the practice of pharmacy are also reinforced in the context of advanced scenarios. The facilitator's role is not to teach the students, but rather to facilitate their discussion. During the semester, this course meets twice a week for two hours. Residents may be scheduled up to 16 sessions per semester.

Experiential Teaching
Clerkship teaching, involving both P3 and P4 student pharmacists, is integrated into the resident practice model. Early in the program, the resident will observe faculty clerkship preceptors and become integrated into various aspects of clerkship teaching. During the residency program, residents will independently precept clerkship students for a minimum of 1 six week rotation block.

Clinician-Educator Residency Certificate Program
The Clinician Educator Training Program is a program to provide training for TTUHSC affiliated PGY1 and PGY2 residents who are interested in developing their academic skills. The primary goal of the training program is to supplement a strong clinical background with the skills needed to become a successful educator. The learning objectives for this program are to develop a personalized teaching philosophy, create evaluable learning objectives and corresponding exam questions for a formal lecture, evaluate students fairly, and to discuss effective teaching methodologies for a given scenario. The program includes didactic and web-based teaching models, mentored facilitator training for small group problem-based learning, and precepting of third and/or fourth-year student pharmacists. Residents also receive instruction in grant-writing, biostatistics, and clinical trial design; submit a project proposal to the institutional review board; and collect, interpret, and publish their results. Additional activities are provided to enhance discovery, integration, and writing skills. The program also includes innovative discussion topics based on needs previously identified by new faculty members. While the program targets residents with an interest in academia, the skill sets gained through the Clinician-Educator Training Program are applicable to a broad range of career opportunities. For PGY-2 residents, completion of this certificate is optional following the completion of an ASHP accredited Teaching Certificate program as a PGY-1 Resident.

Residency Research Project
Residency Project: Residents will complete one research project per year. Residents may choose any type of research project or quality improvement program, provided that the project:

includes generation of original data;
is suitable for publication or presentation at a national pharmacy meeting;
can reasonably be completed within the residency year.

Medication-use Evaluation
Residents are required to complete at least one medication-use evaluation during the residency year.

Manuscript Preparation
Residents are required to submit one manuscript per year for publication in a refereed journal.

Presentation of Research Project
Residents will present their research project at a national meeting during the second half of the residency year that is focused on the education of oncology providers.

The Texas Tech School of Pharmacy was established by the Texas Legislature in 1993 and is part of the Texas Tech University Health Sciences Center. The Texas Tech University Health Sciences Center School of Pharmacy graduated its first class in May 2000. The Texas Tech School of Pharmacy is the first publicly funded pharmacy school to be built in the US in 40 years. Founded upon the idealism that tomorrow's pharmacists must be independent thinking and technologically advanced, all education and training utilizes problem-based learning techniques with a strong emphasis on computer literacy. All course materials are maintained on the School's World Wide Web servers. The main campus for the school of pharmacy is located in Amarillo, with regional campuses in Dallas/Ft Worth, Lubbock and Abilene, Texas. The Dallas/Fort-Worth Regional campus was established in 1999, & has two sites, one resides on the Dallas Veterans Affairs Medical Center campus and the other is within the central Dallas Medical District. Residents are actively involved in didactic and clinical teaching and helping facilitate Pharm.D. students in acquiring problem-based learning skills.

For the fifth consecutive year, Southwestern’s William P. Clements Jr. University Hospital has been named the number 1 hospital in the DFW area by U.S. News & World Report. With the completion of its third 12-story tower, the facility now boasts 751 beds committed to serving our patients and their families in the metroplex and across Texas. Best practices gathered from the nation’s top clinical facilities are incorporated in the design of the new hospital and fully integrate UT Southwestern’s patient care, education, and research missions – elements that make an academic medical center unique among health care providers.

As the region’s only National Cancer Institute-designated cancer center, UT Southwestern’s Simmons Cancer Center offers a level of care and access to innovative treatments that are unsurpassed in North Texas. But we’re not content with simply offering the latest advances in cancer care. Our active research program seeks to uncover the newest scientific discoveries in cancer and bring them to our patients. They offer 13 major cancer care programs. The focus is treating the whole patient while we fight the cancer. In addition to patient care and research, the education and training programs support and develop the next generation of cancer researchers and clinicians. In addition to the recent expansion of Clements University Hospital, ground has been broken on a brand new cancer center, projected opening in 2022.

	Chris Selby, Pharm.D., BCOP Assistant Professor of Pharmacy Practice Specializing in Hematology/Oncology Practice Site: UT Southwestern Clements University Hospital Dr. Selby is an Assistant Professor in the Pharmacy Practice Department with the Texas Tech Health Science Center (TTUHSC) – School of Pharmacy. He graduated from Southern Illinois University Edwardsville – School of Pharmacy in 2014. This was followed by a PGY-1 pharmacy practice residency in Shreveport, Louisiana at University Health and a PGY-2 specialty residency in Oncology at University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in Denver, Colorado. After completing residency, Dr. Selby returned to Shreveport as an inpatient clinical pharmacist, helping to cover both medical oncology and bone marrow transplant patients. Currently, Dr. Selby teaches in the Pharmacotherapy VII – Oncology, Pain, and Palliative Care, as well as, the Advanced Oncology. He is also an active member of American Society of Health-Systems Pharmacists (ASHP) and Hematology/Oncology Pharmacists Association (HOPA).
Preceptors
	Stefanie Conley, Pharm.D., BCOP Dr. Conley is currently the Oncology Investigational Drug Service Clinical Pharmacist Coordinator. She graduated from Purdue University with a Bachelor of Science in Pharmacy degree in 1994 and a Doctor of Pharmacy degree in 2000. She completed an Oncology Specialty Pharmacy (PGY2) Residency at the University of Pittsburgh and was the Oncology Investigational Drug Service Pharmacist for the University of Pittsburgh Hillman Cancer Institute. Over the course of her career, she has actively participated in studies sponsored by the National Cancer Institute, Eastern Cooperative Oncology Group (ECOG), Southwestern Oncology Group (SWOG), NRG Oncology, Alliance and industry sponsored cancer trials as well as phase I trials. Stefanie is currently a member of the ECOG-ACRIN cooperative group, the ECOG-ACRIN pharmacy steering committee, and the Hematology Oncology Pharmacy Association (HOPA). She is a preceptor for the Investigational Drug Service rotation for the PGY2 Oncology Specialty Residency program and PGY1 residency program and serves as a preceptor for pharmacy students.
	Bryan Denbow, Pharm.D.
	Ashley Jones, Pharm.D., BCOP Dr. Jones is a clinical pharmacy specialist at UTSW Clement's University Hospital and the Harold C. Simmons Comprehensive Cancer Center. She graduated from University of Oklahoma College of Pharmacy in 2012. She then completed both her PGY1 residency and PGY2 Hematology/Oncology specialty residency at Nebraska Medicine and University of Nebraska Medical Center (UNMC) College of Pharmacy in Omaha, Nebraska. After completing residency, Dr. Jones became an inpatient oncology specialist in Oklahoma City, Oklahoma where she covered general oncology and hematologic malignancy patients. She ultimately returned to her home in Dallas/Fort Worth and has been at UTSW since 2019. Dr. Jones currently rotates between inpatient and outpatient settings to cover patients with hematologic malignancies and those who receive hematologic stem cell transplants and CAR-T therapy. She is also an active member of HOPA.
	Kailee Gaines, Pharm.D. BCOP Kailee grew up in many different areas of Texas and Kentucky. She obtained her Bachelor of Science at Texas A&M University-Commerce, then continued her education at The University of Texas at Austin College of Pharmacy. She received her Doctor of Pharmacy degree in 2019.
	Christine Hong, Pharm.D., MBA
	Katherine Hill, Pharm.D. Dr. Hill completed a Bachelor of Science in Biology at the University of Louisiana-Lafayette. She received her Doctor of Pharmacy from Presbyterian College School of Pharmacy in Clinton, South Carolina, and completed her PGY-1 pharmacy residency at Ochsner LSU Health Shreveport in Shreveport, Louisiana. Dr. Hill completed her PGY-2 oncology pharmacy residency at Texas Tech University/UT Southwestern Medical Center in Dallas, Texas in 2023. She is a member of the American College of Clinical Pharmacy (ACCP), American Society for Transplantation and Cellular Therapy (ASTCT), Hematology Oncology Pharmacy Association (HOPA), American Society of Health-System Pharmacists (ASHP).
	Rochelle Horadam, RPh. BCOP Rochelle graduated from Purdue University with her B.S. Pharmacy and then obtained her Board Certified Oncology Pharmacist in 1999. She has held positions with Texas Oncology and US Oncology Research totaling 13 years. Rochelle joined the UTSW team in July of 2007 and has served in her current position Clinical Pharmacy Specialist in our Breast Cancer Clinic since March of 2019.
	Shraddha Kansagra, Pharm.D., BCOP Dr. Kansagra received her B.S. Pharmacy in 2007 and her Pharm.D. in 2009, both from the University of Connecticut School of Pharmacy. After completing pharmacy school, she completed her PGY-1 residency at St. Francis Hospital and Medical Center, also in Connecticut. Since then, Dr. Kansagra has held clinical pharmacy positions at Smilow Cancer Hospital at Yale New Haven Hospital, Mayo Clinic, Texas Health Harris Methodist Hospital before joining UTSW in 2018. She is now a Clinical Pharmacy Specialist in the SCCC outpatient multidisciplinary cancer clinics. Shraddha has been involved with oncology pharmacy at a national level, serving on multiple HOPA committees and has also recently received her certification from ACCP in Precision Medicine: Oncology Genomics.
	Megan Ouldhouse, RPh., BCOP
	Hetalkumari Patel, Pharm D, BCOP Currently, Dr. Patel is the Outpatient BMT Clinical Pharmacy Specialist at UT Southwestern Harold C. Simmons Comprehensive Cancer Center. She obtained her Pharm D from the University of Kentucky in 2000, then was a Clinical Pharmacist at University of Kentucky Markey Cancer Center and University of Wisconsin Hospital and Clinics Carbone Cancer Center. Dr. Patel has been a clinical instructor at UK College of Pharmacy and UW College of Pharmacy and has served on local and national organizations including HOPA (Hematology Oncology Pharmacy Association) & ECOG Pharmacy Committee. Her interests include research, supportive therapy for transplant patients and teaching both patients, students, pharmacy residents and other healthcare professionals.
	Katy Rascón, Pharm.D. Dr. Rascón received her Bachelor of Science degree from Baylor University in Environmental Health Sciences and received her Doctor of Pharmacy degree from The University of Houston. She completed her PGY1 Pharmacy Residency at the Michael E. DeBakey Veterans Affairs Medical Center in Houston. Dr. Rascón is currently a member of the American College of Clinical Pharmacy (ACCP), the American Society for Transplantation and Cellular Therapy (ASTCT) and the Hematology/Oncology Pharmacy Association (HOPA).
	Alicia Yn, Pharm.D. BCOP Alicia graduated from St. Louis College of Pharmacy. She completed both PGY1 and PGY2 Oncology at Washington University in St. Louis/Barnes-Jewish Hospital, and specialized in malignant hematology, bone marrow transplant, and cellular therapies.

Resident positions available: 1

Application deadline: January 3, 2024

NMS Code: 698260

Starting date: July 1, 2024

Program length: 12 months

Estimated annual salary: $49,000

Benefits:
Health insurance coverage, dental coverage (additional fee) and retirement benefits. 12 days of vacation leave, 10 days of professional leave and 12 days of sick leave. Travel funds or compensation for Professional Meetings.

Requirements:
Residency applicants must have a Pharm.D. degree, be eligible for licensure in Texas, and be eligible for employment at Texas Tech University HSC Jerry H. Hodge School of Pharmacy. Completion of an ASHP accredited PGY1 residency is also required.

How to apply:
All Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy affiliated residency programs are participating in the Pharmacy Online Residency Centralized Application Service (PhORCAS). More information on PhORCAS can be found on the ASHP-PhORCAS webpage.

The components of the application include:

Curriculum Vitae (CV)
Letter of intent (describe your interest in the residency program and your professional goals and objectives)
Three (3) letters of recommendation forms (located in PhORCAS)
Official transcripts from all pharmacy education

Molly Crosley, Pharm.D.
PGY2 Oncology Pharmacy Resident

Email: Margaret.Crosley@ttuhsc.edu
Hometown: Indianapolis, IN
Pharmacy School: University of Kentucky College of Pharmacy

Residency Program:
TTUHSC Jerry H. Hodge School of Pharmacy - Dallas

About Molly:
Molly is originally from Indianapolis, IN. She attended the University of Kentucky for both her pre-pharmacy and pharmacy education. She completed her PGY1 Pharmacy Residency at Trinity Health Grand Rapids in Grand Rapids, Michigan. Molly is currently a member of the American Society of Health-System Pharmacists (ASHP).

Professional interests:
Oncology, Immunotherapy, Supportive Care, Academia

Personal interests outside of the residency program:
She enjoys traveling, reading, playing board and card games, spending time with family/friends, and discovering new food/restaurants.

2022-2023
Katherine Hill, Pharm.D.

Katherine Hill completed a Bachelor of Science in Biology at the University of Louisiana-Lafayette. She received her Doctor of Pharmacy from Presbyterian College School of Pharmacy in Clinton, South Carolina, and completed her PGY-1 pharmacy residency at Ochsner LSU Health Shreveport in Shreveport, Louisiana. Katherine is currently completing a PGY-2 oncology pharmacy residency at Texas Tech University/UT Southwestern Medical Center in Dallas, Texas. She is a member of the American College of Clinical Pharmacy (ACCP), American Society for Transplantation and Cellular Therapy (ASTCT), Hematology Oncology Pharmacy Association (HOPA), American Society of Health-System Pharmacists (ASHP). Outside of oncology, Katherine enjoys gardening, practicing calligraphy and trying new restaurants around Dallas.

2021-2022
Kaitlin (Katie) Rascón, Pharm.D.

Katie grew up in a military family and has traveled to and lived many places both nationally and internationally. She received her Bachelor of Science degree from Baylor University in Environmental Health Sciences and received her Doctor of Pharmacy degree from The University of Houston. She completed her PGY1 Pharmacy Residency at the Michael E. DeBakey Veterans Affairs Medical Center in Houston. Katie is currently a member of the American College of Clinical Pharmacy (ACCP), the American Society for Transplantation and Cellular Therapy (ASTCT) and the Hematology/Oncology Pharmacy Association (HOPA). In her free time, she enjoys hiking & outdoor activities, reading, playing board games, gardening, spending time with family/friends and discovering new food/restaurants.

2020-2021
Kailee Gaines, Pharm.D.

Kailee grew up in many different areas of Texas and Kentucky. She obtained her Bachelor of Science at Texas A&M University-Commerce, then continued her education at The University of Texas at Austin College of Pharmacy. She received her Doctor of Pharmacy degree in 2019.

Resident Research Project:
Comparative Evaluation of the Efficacy and Safety of CDK 4/6 Inhibitors in the Treatment of Metastatic Breast Cancer

2019-2020
Parnian Eslami, Pharm.D.

Dr. Eslami received her Doctor of Pharmacy degree from University of California, San Diego (UCSD) Skaggs School of Pharmacy and Pharmaceutical Sciences in May 2016. Following her graduation, she worked for about a year and half in outpatient setting. After gaining some work experience, she completed her PGY1 Pharmacy Residency at NorthBay Healthcare/Touro University California in Fairfield.

Resident Research Project:
Evaluation of The Use of Corticosteroids In Management Of Immunotherapy Related Adverse Effects

2017-2018
Danielle Dunn, Pharm.D.

Dr. Dunn received her Bachelor of Science degree from Sam Houston State University in Huntsville, Texas. Danielle graduated from pharmacy school in 2016 from St. John Fisher College – Wegmans School of Pharmacy in Rochester, New York. She completed her PGY1 Pharmacy Practice residency at MaineGeneral Medical Center in Augusta, Maine. Her practice areas of interest include BMT, hematology and infectious disease. Danielle enjoys spending time with family and friends, listening to music, and cheering on the Houston Astros!

Katherine Kelly, Pharm.D.
Dr. Kelly completed her PGY-1 pharmacy practice residency at the VA North Texas Health Care System in July 2015. Katherine is a native Texan raised in Colleyville, TX. Coming from a family of Aggies, Katherine graduated magna cum laude in December 2009 with her Bachelor of Arts degree in chemistry from Texas A&M University. Dr. Kelly graduated with high honors with her Doctor of Pharmacy degree from the University of Texas At Austin and the University of Texas At Austin Health Science Center at San Antonio in May of 2014.

2014-2015
Rene Mani, Pharm.D.

Hailing from Grapevine, TX, Dr. Mani received his Bachelor of Science degree in Molecular Biology from the University of Texas at Dallas in December 2008 and his Doctor of Pharmacy degree from Texas Tech University Health Sciences Center School of Pharmacy in May 2013; additionally, he completed an ASHP-accredited PGY1 pharmacy practice residency with Hendrick Medical Center and Texas Tech University Health Sciences Center School of Pharmacy in Abilene, TX from July 2013 to June 2014.

Chris Selby, Pharm.D., BCOP
PGY2 Oncology Residency Program Director
Assistant Professor
Adult Medicine Division – Pharmacy Practice Department
Texas Tech University Health Sciences Center
Jerry H. Hodge School of Pharmacy

5920 Forest Park Road, Suite 500
Dallas, TX 75235
Phone: (214) 358-9071
Email: christopher.selby@ttuhsc.edu

PGY2 Oncology Pharmacy Residency

Purpose

Description

2022-2023Katherine Hill, Pharm.D.

2021-2022Kaitlin (Katie) Rascón, Pharm.D.

2020-2021Kailee Gaines, Pharm.D.

2019-2020Parnian Eslami, Pharm.D.

2017-2018Danielle Dunn, Pharm.D.